Skip to content
10-Q

Quarterly Report

BEONE MEDICINES LTD. BEIGF ONC

0001651308-25-000075

← back to feed
Filed
May 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 2, 2025 1.4B sh
Long Term Debt Q1 2025 · Mar 31, 2025 $160.16M
Long Term Debt Q1 2025 · Dec 31, 2024 $166.48M
Current Liabilities Q1 2025 · Mar 31, 2025 $1.98B
Current Liabilities Q1 2025 · Dec 31, 2024 $2.21B
Total Liabilities Q1 2025 · Mar 31, 2025 $2.34B
Total Liabilities Q1 2025 · Dec 31, 2024 $2.59B
Current Assets Q1 2025 · Mar 31, 2025 $3.9B
Current Assets Q1 2025 · Dec 31, 2024 $3.99B
Total Assets Q1 2025 · Mar 31, 2025 $5.84B
Total Assets Q1 2025 · Dec 31, 2024 $5.92B
Cash And Equivalents Q1 2025 · Dec 31, 2024 $2.63B
Cash And Equivalents Q1 2025 · Mar 31, 2024 $2.79B
Shares Diluted Q1 2025 · Mar 31, 2024 1.36B sh
Capex Q1 2025 · Mar 31, 2024 $156.58M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$308.57M
Stockholders Equity Q1 2025 · Mar 31, 2024 $3.36B
Stockholders Equity Q1 2025 · Dec 31, 2023 $3.54B
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.19
Eps Basic Q1 2025 · Mar 31, 2024 −$0.19
Sga Expense Q1 2025 · Mar 31, 2024 $427.43M
Rd Expense Q1 2025 · Mar 31, 2024 $460.64M
Net Income Q1 2025 · Mar 31, 2024 −$251.15M
Operating Income Q1 2025 · Mar 31, 2024 −$261.35M
Gross Profit Q1 2025 · Mar 31, 2024 $626.72M
Revenue Q1 2025 · Mar 31, 2024 $751.65M